Open Public Hearing 1.Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC] 1.Congresswoman Donna M. Christensen, M.D. Chair,

Slides:

Advertisements

Similar presentations

The Costs and Consequences of Unstable Health Insurance Coverage Jennifer N. Edwards, Dr.P.H. The Commonwealth Fund June 27, 2005.

Advertisements

The Fellowship Toolbox Perspective from Fellowship Alumna J. Nwando Olayiwola, MD, MPH, FAAFP November 13, 2012.

American Cancer Society Patient Resource Navigation Program Brandon Costantino University of Maryland Medical Center.

Guiding Principles for the Care of People With or at Risk for Diabetes

CR-1 ATACAND ® (candesartan cilexetil) Cardiovascular and Renal Drugs Advisory Committee Bethesda, Maryland July 18, 2002 C.

Project Immunize Virginia Diane Helentjaris, MD, MPH Director, Office of H1N1 Response Virginia Department of Health March 25, 2010 West Henrico Health.

“ Telehealth: Supporting Diabetes Self-Care ” 9 th Annual INET Mini-Conference June Four Season Hotel, Toronto.

A-1 Pravastatin-Aspirin Introduction Todd Baumgartner, MD, MPH Vice President Regulatory Sciences Pharmaceutical Research Institute Bristol-Myers Squibb.

“Wireless Diabetes Program: A patient, hospital and primary care collaboration ” 8 th Annual INET Mini-Conference June Metro Toronto Convention.

University of Louisville The Department of Bioinformatics and Biostatistics.

The Only National African American Breast Cancer Survivorship Organization.

Open Public Hearing Speakers Nonprescription Drugs and the Endocrinologic Drugs Advisory Committees January 23, 2006.

Value Based Drug Development April 21 st, 2015 Moderator: Ellen V. Sigal, PhD Chair & Founder, Friends of Cancer Research 1.

NATIONAL DEATH INDEX U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics.

HC70A Winter 2006 Genetic Engineering in Medicine, Agriculture, and Law Professor Bob Goldberg Class Announcements 2/2/06.

Fiscal $2.12 million Fiscal $1.73 million Fiscal $1.25 million Fiscal $3 million OFFICE OF ADVANCEMENT Department of Surgery.

Scientific, Economic, Social and Ethical Implications of Developing Ethnic-Specific Therapeutics, Such As BiDil The National Human Genome Center and Department.

Right Care Initiative University of Best Practices Jerry Penso, MD, MBA February 7, 2011.

Bio-Tech Israel 2005 Conference & Exhibition May 24 – 26, 2005 David Intercontinental Hotel, Tel Aviv, Israel.

The Importance of Professional and Community Involvement Taking Action to Improve Oral Health Leslie Stevens, RDH Dental Program Coordinator Allegany County.

CEO Report to the Hospital Authority Board Open Session

Class of 2013 Fellows May 20, 2013 Sheraton Boston Hotel Boston, MA USA.

Informing Public Policy to Address Health Care Disparities Boisey Barnes, MD, F.A.C.C. Founding Member and Trustee Association of Black Cardiologists.

JOINT ADVISORY COMMITTEE ON COMMUNICATIONS CAPABILITIES OF EMERGENCY MEDICAL AND PUBLIC HEALTH CARE FACILITIES Structure for Advisory Committee.

1 CEO Report UWHC Authority Board Donna M. Katen-Bahensky President and CEO February 3, 2010.

UAMS College of Medicine New Faculty Orientation August 24 th, 2010 Opening SessionClinician SessionResearch Session.

“Strategies to Improve the Care of Persons with Dementia in Rural and Remote Areas” Principal Investigator Debra Morgan, PhD, RN CIHR New Investigator,

July 31, 2013 APA Convention, Honolulu, HI MENTORING OF EARLY CAREER MINORITIES IN HEALTH-RELATED RESEARCH.

Obesity: definition, clinical aspects, epidemiology, public health impact DioGenes & Hepadip Course Genomics on Obesity June 7, 2007, Toulouse Thorkild.

Certification/Adoption Workgroup EHR Usability Hearing – April 21, 2011 Letter to the National Coordinator June 8, 2011 Marc Probst, Co-Chair Larry Wolf,

TEACH: LEVEL II – CLINICAL POLICIES AND GUIDELINES STREAM TEACH Plenary NYAM August 8 th, 2012 Craig A Umscheid, MD, MSCE, FACP Assistant Professor of.

CI-1 CRESTOR ® (rosuvastatin calcium) Tablets Endocrinologic and Metabolic Drugs Advisory Committee Bethesda, Maryland July 9, 2003 C.

Guest Speaker: Richard JaeBong (Rick) Lee, MD, PhD Assistant Physician, Department of Medicine Massachusetts General Hospital Remarks: Mr. Mark Kennedy,

CI-1 ATACAND ® (candesartan cilexetil) Cardiovascular and Renal Drugs Advisory Committee Rockville, Maryland February 24, 2005 C.

7asdf Omapatrilat in the Treatment of Hypertension NDA FDA Cardiovascular and Renal Drugs Advisory Committee Meeting July 19, 2002 Anthony Waclawski,

Is there evidence to justify different claims for different drug classes? Presentation to: Cardiovascular & Renal Drugs Advisory Committee Food & Drug.

Synchrotron Radiation for Macromolecular Crystallography Report of the Office of Science and Technology Policy Working Group on Structural Biology at Synchrotron.

BDH Discovering Tomorrow’s Healthcare Solutions Today Clinical Research Services, Inc. Basil Halliday, M.Sc. President & CEO BDH Clinical Research Services.

Joycelyn Elders By Aracely Espinosa March 4,2004.

AA-1-1 Mark B. Kreston President, Worldwide Consumer Medicines 7asdf.

Summer Research Opportunities Office of Medical Student Research & John B. Graham Medical Student Research Society October 17, 2013.

David M. Deci, M.D. Director Office of Medical Student Education Associate Professor, Department of Family Medicine University of Wisconsin School of Medicine.

PRESENTED BY Judy Hartegan Brad Thomas Doris Jackson.

Pradeep Srivastava MD Maryland. Board certifications that he earned include American Board of Internal Medicine Certification in September 1988, North.

UIP Administrative Structure

Prof. Young-Kook Lee Present Position Education Experience Honors

Hypertension-Lipid Connection: Introduction

Alfredo G. Torres, MS, PhD Director of Faculty Diversity Professor

Department Heads Breakfast During the ASN Scientific Sessions At Experimental Biology Monday, April 24, 2017 Hilton Chicago - Williford Room A 1.

CEO Report to the Hospital Authority Board Open Session

Teaching-Research Balance in the Changing Classroom

ASA Monitor. 2017;81(10):8-11. Figure Legend:

Academic Appointments

REFUGEE HEALTH IN THE 21ST CENTURY: THE CASE OF SYRIA

Annual Business Meeting & Class of 2017 Fellows

The Epidemiology of Mountain Bike Park Injuries at the Whistler Bike Park, British Columbia (BC), Canada Zachary Ashwell, MSME, Mary Pat McKay, MD, MPH,

Anesthesiology Grand Rounds & Journal Club Denham S. Ward, MD, PhD

Editorial Staff The Journal of Thoracic and Cardiovascular Surgery

Mary Nettleman, MD, Barbara L. Schuster, MD

The Epidemiology of Mountain Bike Park Injuries at the Whistler Bike Park, British Columbia (BC), Canada Zachary Ashwell, MSME, Mary Pat McKay, MD, MPH,

LSU Health Sciences Center – New Orleans Department of Microbiology, Immunology and Parasitology SPRING 2009 SEMINAR SERIES “Understanding the Mechanisms.

“Controversies in the prevention of mother-to-child transmission in

Precise capture of thoracic morbidity and mortality: Essential to the process and culture of quality improvement Anna L. McGuire, MD, MSc, FRCSC, John.

Mahendra Rao, MD Mayo Clinic Proceedings

Volume 24, Issue 2, Pages (August 2016)

BDHP Cancer Theme Seminar Haematology Cancers

Dr. Charles drew Miriya.

George H. Meier, MD, Bauer Sumpio, MD, PhD, Henry R

The Potential of Medicare Accountable Care Organizations to Transform the American Health Care Marketplace: Rhetoric and Reality David J. Ballard, MD,

PCPM Work Group Primary Care Payment Model (PCPM) Chairs

Presentation transcript:

Open Public Hearing 1.Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC] 1.Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC] Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

Open Public Hearing 2.Gary A. Puckrein, Ph.D. National Minority Health Month Foundation 2.Gary A. Puckrein, Ph.D. National Minority Health Month Foundation Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

Open Public Hearing 3. B. Waine Kong, J.D., Ph.D. CEO – American Association of Black Cardiologists [ABC] 3. B. Waine Kong, J.D., Ph.D. CEO – American Association of Black Cardiologists [ABC] Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

Open Public Hearing 4.Debra Lee Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

Open Public Hearing 5. Shomarka Omar Y. Keita, M.D., D.Phil. Medical Officer - Department of Human Services, District of Columbia Research Associate - Anthropology Department, Smithsonian Institution 5. Shomarka Omar Y. Keita, M.D., D.Phil. Medical Officer - Department of Human Services, District of Columbia Research Associate - Anthropology Department, Smithsonian Institution Cardiovascular and Renal Drugs Advisory Committee June 16, 2005 ****

Open Public Hearing 6. Jonathan Kahn, J.D., Ph.D. Assistant Professor Hamline University School of Law 6. Jonathan Kahn, J.D., Ph.D. Assistant Professor Hamline University School of Law Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

Open Public Hearing 7. Charles L. Curry, M.D., FACC, FACP President - International Society on Hypertension in Blacks 7. Charles L. Curry, M.D., FACC, FACP President - International Society on Hypertension in Blacks Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

Open Public Hearing 8. Basil Halliday, M.Sc. President & CEO - BDH Clinical Research Services 8. Basil Halliday, M.Sc. President & CEO - BDH Clinical Research Services Cardiovascular and Renal Drugs Advisory Committee June 16, 2005 ****

Open Public Hearing 9.Charles N. Rotimi, Ph.D. National Human Genome Center Howard University 9.Charles N. Rotimi, Ph.D. National Human Genome Center Howard University Cardiovascular and Renal Drugs Advisory Committee June 16, 2005 ****

Open Public Hearing 10. Charmaine Royal, Ph.D. National Human Genome Center Howard University 10. Charmaine Royal, Ph.D. National Human Genome Center Howard University Cardiovascular and Renal Drugs Advisory Committee June 16, 2005 ****

Open Public Hearing 11. Olivia Carter-Pokras, Ph.D. Associate Professor – University of Maryland, School of Medicine, Dept. of Epidemiology 11. Olivia Carter-Pokras, Ph.D. Associate Professor – University of Maryland, School of Medicine, Dept. of Epidemiology Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

Open Public Hearing 12. Lucille C. Norville Perez, MD National Health Director - National Association for the Advancement of Colored People 12. Lucille C. Norville Perez, MD National Health Director - National Association for the Advancement of Colored People Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

Open Public Hearing 13. Dianna Wells Cardiovascular and Renal Drugs Advisory Committee June 16, 2005